Реакция #1726720

ord-77b9f0875b21484a8e01ba4ba82811f9

Уравнение реакции

O=C(O)C(F)(F)F
TFA
NC(=O)c1cc(-c2nnn[nH]2)ccc1O
2-hydroxy-5-(1H-tetrazol-5-yl)benzamide
CC(C)(C)OC(=O)N1CCC(=O)CC1
1-Boc-4-piperidone
C1COCCN1
morpholine
CC(C)(C)OC(=O)N1CCC2(CC1)NC(=O)c1cc(-c3nnn[nH]3)ccc1O2
1′-(tert-butyloxycarbonyl)-6-(1H-tetrazol-5-yl)spiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one
Выход 21.6%

Растворители

Условия реакции

Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    Температураis refluxed for 72 hr
  2. 2
    ДругоеThe MeOH is removed by rotoevapoation
  3. 3
    Другоеthe residue is purified by preparative TLC

Методика

A mixture of 75 mg (0.37 mmol) of 2-hydroxy-5-(1H-tetrazol-5-yl)benzamide, 110 mg (0.55 mmol) of 1-Boc-4-piperidone, and 71 μL of morpholine in 8 mL of MeOH is refluxed for 72 hr. The MeOH is removed by rotoevapoation and the residue is purified by preparative TLC to give 29 mg (0.08 mmol, 15% yield) of 1′-(tert-butyloxycarbonyl)-6-(1H-tetrazol-5-yl)spiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one which on treatment with 40% TFA in dichloromethane at room temperature for 3 hr. gives the TFA salt of 6-(1H-tetrazol-5-yl)spiro[1,3-benzoxazine-2,4′-piperidine]-4(3H)-one in quantitative yield.

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US08110570B2uspto-grants-2012_02